GRAFTECH INTERNATIONAL LTD
GRAFTECH INTERNATIONAL LTD Q3 FY2024 earnings call
November 12, 2024 · fiscal period ended 2024-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-11-12
Management highlights
Safety: Year-to-date recordable incident rate improved but still needs further improvement. ### Commercial: - Sales volume increased 9% year-over-year and 13% year-to-date in Q3, with low double-digit sales volume growth expected in 2025. - Entered new strategic multiyear electrode sales agreements. - Initial trials of new 800-millimeter electrodes conducted by a key customer in North America. ### Operations: - Achieved 28% year-over-year decrease in cash COGS per metric ton in Q3, exceeding expectations; increased full-year guidance for cash COGS improvement. - Generated $20 million of free cash flow in Q3. - Announced a financing transaction to strengthen financial foundation, including new capital, debt maturity extension, and revolver replacement.
Segment performance
No detailed breakdown of product segments with revenue contribution provided in the transcript.
Guidance
Sales Volume: Expect low double-digit sales volume growth in 2025. ### Cash COGS: - Anticipate approximately 20% year-over-year decline in cash COGS per metric ton for 2024, resulting in cash COGS per metric ton of approximately $4,400; further decline expected in 2025. ### Liquidity: - Ended Q3 with total liquidity of approximately $254 million. - New financing includes a $275 million delayed draw term loan, debt maturity extension for existing notes, and replacement of the revolving credit facility.
Risks
Industry Cyclicality: Current down cycle in the industry poses challenges. ### Geopolitical Factors: Impact of trade tariffs and geopolitical conflicts on steel and electrode markets. ### Pricing Volatility: Fluctuations in spot pricing for electrodes and stability/volatility of needle coke pricing.
Q&A highlights
Q: Bill Peterson on near-term pricing and needle coke pricing A: Tim and Rory discuss spot pricing decline, noting it's fallen to about $4,150 on a weighted average basis, while needle coke prices remain relatively stable in the $1,000 to $1,300 range, expecting future pricing rebound as demand picks up Q: Alex Hacking on contracting season and competitor price increase A: Tim talks about ongoing negotiations for Q1 and first half 2025 deliveries, noting a competitor's 20% price increase is a supportive step for industry health, with ongoing active dialogues with customers Q: Arun Viswanathan on steel utilization and market trends A: Tim discusses sales volume growth expectations, regional market outlooks including Europe's hand-to-mouth market and U.S. steel production expectations, expecting slight recovery in demand heading into 2025 Q: Kirk Ludtke on pricing stabilization and debt covenants A: Tim and Rory discuss longer-term agreements being used for strategic customer partnerships, and Rory comments on customary covenants in the delayed draw term loan with no surprise restrictions preventing access Q: Matt Vittorioso on debt transaction and leverage A: Tim and Rory discuss the debt transaction as a means to improve liquidity and strategic flexibility, with Tim stating the deal provides cost-competitive capital, maturity extension, and strategic flexibility, and Rory noting customary leverage covenants Q: Abe Landa on debt transaction details and tariffs A: Rory discusses inclusion of majority foreign assets in collateral, and Tim comments on geopolitical factors like trade tariffs, noting impact on markets but expecting support for domestic steel markets
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
November 12, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.